{"name":"Shanghai Pharmaceuticals Holding Co., Ltd","slug":"shanghai-pharmaceuticals-holding-co-ltd","ticker":"","exchange":"","domain":"shanghai.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"LTS 0.5mg","genericName":"LTS 0.5mg","slug":"lts-0-5mg","indication":"Other","status":"phase_1"},{"name":"SPH3127 tablet Dose 1","genericName":"SPH3127 tablet Dose 1","slug":"sph3127-tablet-dose-1","indication":"Other","status":"phase_3"},{"name":"B001","genericName":"B001","slug":"b001","indication":"Other","status":"phase_2"},{"name":"LT3001 Drug:low dose","genericName":"LT3001 Drug:low dose","slug":"lt3001-drug-low-dose","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"LTS 0.5mg","genericName":"LTS 0.5mg","slug":"lts-0-5mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPH3127 tablet Dose 1","genericName":"SPH3127 tablet Dose 1","slug":"sph3127-tablet-dose-1","phase":"phase_3","mechanism":"SPH3127 tablet Dose 1 is a drug with an unknown mechanism of action.","indications":[],"catalyst":""},{"name":"B001","genericName":"B001","slug":"b001","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"LT3001 Drug:low dose","genericName":"LT3001 Drug:low dose","slug":"lt3001-drug-low-dose","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQU0RZUHNRWE1TblRiVlhDR3NlSEdybl9DTmY1ZDA3R29vVE1OaTNhZ1ZVZ3J4ajA1ZGpPWlBWRXBHTkVOT0JXcE53N1dHZnBvdEVLa19yeGRMSTJNT0RVUUdiczNqQUlVcklNN05YRndQOUxEWGpTWUY1V3psbEkzTFgyLU83WUdRcTJJUDIyN3pLcWtwOS1KRG5HWHBuVWgyUVh2TXZ2NjdHdXZ2ZVpYb1FTYjlWcm52?oc=5","date":"2025-05-27","type":"deal","source":"Fierce Pharma","summary":"Novartis expands strategic collaboration with Shanghai Pharma in China to cover eye drugs - Fierce Pharma","headline":"Novartis expands strategic collaboration with Shanghai Pharma in China to cover eye drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQRjRubmRVT19PVEtvc0ZzVF9PaElyWDlVYTlxRUdGbmZMN2s1XzdUajNPLU1Galp6ZEZtamVWRDA2Ul9TcHR2TllEQmFXWWgybkxLRkRNS083Umdxb1k0X3F0WlBabHNuYmZYdUJUSzZZNlFadkNWSDlKaEx2ZHAtN3J0bmc4Z2oyaE5Bc2IzVnVab1cya3BPdFRadlBWRThPRGtsRFdRT1VxV3QxeHNSanNqcDc?oc=5","date":"2025-01-01","type":"pipeline","source":"Bloomberg.com","summary":"Li Ka-Shing-Backed Hutchmed Sells Stake in Unit for $608 Million - Bloomberg.com","headline":"Li Ka-Shing-Backed Hutchmed Sells Stake in Unit for $608 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNczZLeXhPbzBSNzctRVk3RjUwWlZlZHlucmQzRl9hMGpiWWxnV3dkTnZ1eWdveVAwb09PMmJXMzJKOG1PdnNlS1ItcTFEZFMyVjdoWXluUm1tRlRQS3BBSUhBcUtkZDFEbkhkOTdPeml1dEFKbjdRQmpJdEZ3QmhMalVsMWx4eUJvYmNBU08tTGtGWXJCWDd3ckoybXZydjVJQnhoN190cTFvckhaWHdZbS1QNWszdlp6SmlUSHdMNUF3NmJ0anc0VF9LMnFfZkdBcVRySVFkU2FFWTRWUHJQampTRGktWTloa2lwZjRNZlg2Wk1EdDM1cTIxaw?oc=5","date":"2025-01-01","type":"pipeline","source":"Quiver Quantitative","summary":"HUTCHMED Announces Divestment of 45% Stake in Shanghai Hutchison Pharmaceuticals to Focus on Innovative Medicines and R&D Pipeline - Quiver Quantitative","headline":"HUTCHMED Announces Divestment of 45% Stake in Shanghai Hutchison Pharmaceuticals to Focus on Innovative Medicines and R&","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQSTkyRHNwcVdGSDBhbmJhdjRPNmYtNGc4REdxSVdNaFhEUzNaaG0weXNVb0ZhQTJ1eVRvT3NfWGdQN3lkSFZxYzhpTVFTOE44UFpZQXEtQXVJR0poZ0pUX0p5Rmo3SXlRaWdVLTF3eFo1Q1BVSDBteGVWdGhUSG8wZnNqSXBSZ0ZKQnhiQ1VRR0RpRm0xRVVVVTNvVS1ncFdjTk5WTks1V0VMUDZtUlYtZE5nVmd3YW13ZVZ6LTVxOTh1M1J0ZEpXcV9DNGRhNzU3cHZTeWhjeDh2SW0wX2ptMWZn?oc=5","date":"2024-01-24","type":"pipeline","source":"Hong Kong Science & Technology Parks Corporation ('HKSTP'","summary":"Shanghai Pharmaceuticals Opens “01LABS@Hong Kong” Co-incubator at Science Park - Hong Kong Science & Technology Parks Corporation ('HKSTP'","headline":"Shanghai Pharmaceuticals Opens “01LABS@Hong Kong” Co-incubator at Science Park - Hong Kong Science & Technology Parks Co","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNUkF2TFhEdEQ4Uzkzb1YwMnZjQmVGVGF4N1c1WGZaZ1FOR1d5UDJJQ29VNVVnbGJfeDNNellBUlB6MnFpOU01SDNqZGhwdlBuaXY2RVFhWXlLV0VIUEx5MnllV3hWOXl6UEZwQUg0YXlHSVNIeXJWcGh0aFhzRHdXdEE0RERsY2Voai1VSlhwUUVXZ1BFTDZQVDNPeEJNMzk2eW1zWA?oc=5","date":"2023-09-04","type":"pipeline","source":"Yicai Global","summary":"Shanghai Pharma Dips After Regulators Put Former Execs Under Investigation - Yicai Global","headline":"Shanghai Pharma Dips After Regulators Put Former Execs Under Investigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPS0pYR1QwbFFCWHdPVHN1ZjI1Vzd0UzVwMVl4TEZscU4yN0hUY3NhS1dYVGQyd0c5YS1hQ0p1V0duc0dHZWE2Nm5WTUxmaVo0ZnFSMnFIX1BZX1VxV19EanhaN2F4RXlVdmZSbUR5NFM0Zkx0TjB3TWtMZnpMVWNHX21ZN1NpN0tLcEZWNEFGWEQ5YjNSbXc4MWlUa08wMDRZNW1KeVdFU0JGRDkzYmkyNVV3NV91MllTWnFfYi1WUGhVdEszZHI3ZHo2N1hqVFRrLUFHVQ?oc=5","date":"2021-07-02","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Shanghai Pharma and Russia’s Biocad form joint venture to sell cancer and autoimmune drugs in China - Generics and Biosimilars Initiative","headline":"Shanghai Pharma and Russia’s Biocad form joint venture to sell cancer and autoimmune drugs in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxQSGU5ZEpaU2hJTGRGMlFiMkx3TzFsRzVNaHE4S0dtbmJTdHBwZWstS1pWWS1pLWtNZ2Ewa3dTZGFLTkZxS2RGYXM1cVo1SDV1MVhyeS04aHA2NDNhY0Jxa1RuQ1Nid3kxZW05cEZ1TTVnTGFKV0Ixb2cxLUFHUjNQWjEtRTVQczdwaXptVlE1VmN2T2JyLVR0ZTVIZlJBbVh6aEE3Q2Z5RnVZQzNLaE93N2RxSjJEV0RLLUs0TFRLTkctdVhYUGlvZDlpNEJvMzQ4dDVQWTFObXJMWnRRdXN3bU4zbGJkdllnYzgydTA4dlNhMUFWdThKN0VhZW1KVFUxUG85SlNhODh2R2VlY2FfRmVubS1NUU95QnVMb3M5cFltUDNNbm5xMk9ua3MtaTRlR3RxV19TN28?oc=5","date":"2020-08-06","type":"deal","source":"PR Newswire","summary":"ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies - PR Newswire","headline":"ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPeWRDaVlQa0xzcktiR3N2NkdER0pYLS13Mm45N2d1dFVMRjJVaV9iOFpQd21nRU9xZEw1a3lJRV9fV19haXJiSm9BLUxpcFV1R3Z3WWxqcUtYa1c5d2VPQjgyYTlBeVlBTzhSeDlYTDV0ODcxSFJaZFNKUzVHU3ItZ2hJa3FMTUlPalJwZTVIS0tnUVROV1BRS2VQRkVuZHJIMERHdl82c0VjZF9vSkx4Yk5NTkxyNmsyV3BQZ3hvVQ?oc=5","date":"2018-05-30","type":"pipeline","source":"Zacks Small Cap Research","summary":"DMA.V: What Does the Shanghai Pharma Acquisition Mean to DiaMedica? - Zacks Small Cap Research","headline":"DMA.V: What Does the Shanghai Pharma Acquisition Mean to DiaMedica?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPTlo2WUtvS1JHdHo1emtGV3dJT0pBLVQ5alhvVnRiY0hPUjVzQklZNUNEQnA2NVozQ0FCWGdORkJMaGZqelJpZnpTU1FnY1lWaTAtZTVSUkN3cHQwb1YyX1o1eldqUkYwNWFOWlQ4TTNGWUg5Q2tzcXUxNG90dWVKYXBZem1BR2dIb1NBcEZfai1iYW1rblFiekRvVnd1RW9LRzNNM2ZfWWNQM21RbG1vbWNURTJCRklNZDFYSnNEOHFaQQ?oc=5","date":"2017-11-15","type":"deal","source":"Caixin Global","summary":"Shanghai Pharma to Buy Cardinal Health’s China Business for $1.2 Billion - Caixin Global","headline":"Shanghai Pharma to Buy Cardinal Health’s China Business for $1.2 Billion","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2017-11-15","type":"deal","source":"South China Morning Post","summary":"Shanghai Pharmaceuticals acquires Cardinal Health’s China business - South China Morning Post","headline":"Shanghai Pharmaceuticals acquires Cardinal Health’s China business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxORE1nRWEzS2x4U29fX3NVZWMwN1R2dURrY0JvbWNMTkgzUzdFSVFqNll6SmhoV2ZpMGkwV01raXE3LWtaWkluSV84cjF3VDExLXY0bXowM1VyV29DX0xITEdnTUV2VmJ3eXZsTlJzQUZtTkpubWJ4QkJxb2duaGF6M19tcGZwQTlFVjRoZnNhOUR0YVd1Q1IyalpSTndVV0Q2NnQwZ3VPMFdBZ9IBrwFBVV95cUxOLWdybE1qQmNrazhvZEpfOEFCQVlTdVNmQ2cweU5KNzFTSy0tNEFXeTVnclNIcDNvc19NTjRhd1pGVlA4d2N1QTFwS0w3MmhPMDBMNGJMSktfTkFSclBrdVNyVklwTloxRnhDdkFqREp6LWEyVTF4Q1VYUi1RRlhNRmxEOEc1QTVvb2pEc2dFd0s1aVNWYUpPNl8xNzVuamVEQ1VqY2pmWEFJbnZhZWtR?oc=5","date":"2017-08-14","type":"pipeline","source":"CNBC","summary":"China's Fosun, Shanghai Pharma say bid for stake in U.S. drug maker Arbor - CNBC","headline":"China's Fosun, Shanghai Pharma say bid for stake in U.S. drug maker Arbor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9fYXFjc2dBQXVOS0RacmZ6SXRUMUhuUUN5LTdYNzZJem1xRHBjWFplSEx0amJHZVlsQkpiWGllUnVPVWVTcWNnOTR1SDhmeUlGc0JnODZVTXZoUGUyUklRWHBDV2ZkWkNkMl9LS3FMTFJERXpHVml6SWJ3?oc=5","date":"2016-08-05","type":"deal","source":"China Daily","summary":"Shanghai pharma firm to buy 60% Vitaco stake - China Daily","headline":"Shanghai pharma firm to buy 60% Vitaco stake","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_1":1,"phase_3":1,"phase_2":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}